menu

Young Researcher Award
Program

What is the NewAmsterdam Pharma (NAP) Young Researcher Award (YRA)?

NewAmsterdam Pharma is pleased to announce the creation of the NewAmsterdam Pharma (NAP) Young Researcher Award (YRA). This program was created by NAP Medical Affairs to provide young investigators with the means to explore research in metabolic diseases. NewAmsterdam Pharma is proud of the scientific excellence that is interwoven through all of our efforts to develop life changing medicines. NAP believes that allowing early career investigators to “think out loud” at the bench and/or the clinic will foster innovation, creative thinking and long strategic planning as young researchers prepare for the next phase of their professional journeys.

Eligibility

The NewAmsterdam Pharma YRA provides research grants to basic and/or clinical post-doctoral fellows and junior faculty members at eligible academic or non-profit institutions. Potential investigators are invited to submit proposals that are clinical, basic, translational and/or outcomes, i.e. real-world evidence, in nature or artificial intelligence. Proposals should address topics related to hypercholesterolemia, lipid biology, atherosclerotic cardiovascular disease and lipoprotein function and metabolism.

Overview

Grants will be reviewed and awarded by an independent review committee of experts in lipid biology and medicine. The grants are for two years. Funding for the second year is contingent upon a progress review of year one.

YRA Deadlines and Important Dates

  • 1 April 2025 – Application Deadline (Late and incomplete submissions will not be considered)
  • 1 May 2025 – Successful applicant and institution are notified of the award
  • 1 July 2025 – Grant must be signed by the investigator, mentor and institution and returned to NAP for funds to be dispersed

Young Researcher Award Funds

  • The YRA funds are paid directly to the grantee’s institution
  • Grants are $50,000 per year for up to 2 years. Year 2 funds will be renewed for an additional year assuming sufficient progress
  • The grant may be transferred to another investigator if needed upon renewal for the second year after approval from NewAmsterdam Pharma (ex. after completion of 1-year fellowship)
  • Grant funds may only be used as described in the approved grant proposal
  • Receipt of this grant does not preclude funding support that the applicant receives from his/her institution or other entities
  • Proposals that duplicate on-going NewAmsterdam Pharma supported research, involve obicetrapib or other compounds, are not eligible for the Young Researcher Award

Applicant Eligibility and Qualifications

  • Mentors may submit the application on behalf of a proposed investigator – that is, the mentor can apply with the intention of assigning this project to an incoming fellow
  • Applicant may not have more than 3 years of post-doctoral research experience at the time of grant award
  • U.S. residents working full-time and currently in training are eligible to apply
  • Investigator must be either a United States citizen, in possession of a current student visa or a permanent alien resident, specifically:
    • U.S. Citizen
    • Green Card – permanent residency visa – unlimited duration, can lead to US Citizenship
    • H1B Visa – the primary U.S. Work Visa for professionals & students from all over the world or in the USA, who work in specialty occupations. Valid up to 6 years, dual intent visa (can apply for Green Card)
    • E3 Visa – similar to the H1B but is available to Australian Citizens only
    • TN1 Visa – similar to the H1B but is available to Canadian & Mexican Citizens only
    • J1 Visa (must be valid until January 2027)

Young Researcher Award Program Requirements

  • Funded research must be conducted in an academic or non-profit institution
  • Funded research must be conducted under the supervision of an experienced mentor at the sponsoring institution
  • Proposed research must have anticipated completion timeline of 2 years or less
  • The grant cannot be transferred to an alternate investigator or institution in the event the original institution and investigator dissolve their association without approval by NewAmsterdam Pharma
  • NewAmsterdam Pharma Medical Affairs must immediately be notified in writing, with appropriate justification, if the sponsoring institution anticipates any delays related to these terms
  • Expected Outcomes: submission of data for external presentation and/or publication within 2 years of initial funding

Application Materials

The following must be submitted via email to Your MSL to apply:

  1. Grant Request Letter Must be on institutional letterhead, written and signed by the Department Chair, Division Chief or Training Program Director and include:
    • Academic term dates for investigator’s current position if applicable (e.g., July 1, 2024 to June 30, 2026)
    • Statement of:
      • mentor’s qualifications to supervise and train the investigator
      • scientific prowess of the institution
      • institutional commitment to advancing the care of patients with cardiology or metabolic disease
  2. Current Curriculum Vitae or NIH Biosketch
    • Mentor (required)
    • Investigator (required if known)
  3. Research Proposal (preferably not to exceed 5 pages) Proposal to include:
    • Introduction, research objectives and rationale
    • Background and significance
    • Specific area of research
    • Preliminary data (if available)
    • Design and methods (including statistical analyses)
    • Patient population if applicable
    • Investigator’s role in design and execution of research proposal
    • Detailed budget, including other funding sources (if applicable)
    • References
  4. Letter of Support from Mentor
    • Detail the eligibility, scientific skills, and background of the investigator and how the grant would be beneficial for the development of this young investigator

    OR, if investigator not yet identified,

    • Describe the selection process for identifying an investigator to complete the funded research and how the grant would be beneficial at his/her institution for developing a young investigator
  5. Formal brochure/overview of training program or department

Contact Information

For more information, please contact NewAmsterdam Pharma Medical Affairs at your MSL.